Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FD937
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,373
Award facts
- Contract value 100% obligated
- $22,373.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $22,373.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a completion date of November 19, 2025. This non-set-aside competitive award was issued on November 18, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. The SPE2DX prime IDC serves as a flexible platform enabling AmerisourceBergen to supply pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V regional contracts involving multiple contractors.
Quick answers
Who was awarded contract SPE2DR26FD937?
SPE2DR26FD937 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FD937 worth?
The government has obligated $22,373 on SPE2DR26FD937.
Is contract SPE2DR26FD937 an order under another contract?
Yes. SPE2DR26FD937 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD937 competed?
The extent of competition for SPE2DR26FD937 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award